Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1531-18-6

Post Buying Request

1531-18-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1531-18-6 Usage

General Description

2-Ethylisonicotinonitrile is a chemical compound used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is a derivative of isonicotinic acid, with the ethyl group attached to the 2-position of the pyridine ring and a nitrile group at the 3-position. The compound is a yellow liquid with a faint odor, and it is flammable and potentially toxic if ingested or inhaled. 2-Ethylisonicotinonitrile is primarily used in the production of various drugs and crop protection products, and it is important for its role in the pharmaceutical and agricultural industries.

Check Digit Verification of cas no

The CAS Registry Mumber 1531-18-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,3 and 1 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1531-18:
(6*1)+(5*5)+(4*3)+(3*1)+(2*1)+(1*8)=56
56 % 10 = 6
So 1531-18-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2/c1-2-8-5-7(6-9)3-4-10-8/h3-5H,2H2,1H3

1531-18-6Synthetic route

4-bromo-2-ethyl-pyridine
156761-88-5

4-bromo-2-ethyl-pyridine

potassiumhexacyanoferrate(II) trihydrate

potassiumhexacyanoferrate(II) trihydrate

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With palladium diacetate; sodium carbonate In N,N-dimethyl acetamide at 135℃; for 2h; Temperature; Inert atmosphere;95.9%
2-ethyl-4-pyridinecarboxamide
3376-95-2

2-ethyl-4-pyridinecarboxamide

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With di(n-butyl)tin oxide In toluene Heating;95%
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 40℃;95%
With di(n-butyl)tin oxide In toluene Dehydration; Heating;93%
ethionamide
536-33-4

ethionamide

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With pyridine; aryl chlorothionoformate In dichloromethane for 5h; Ambient temperature;95%
With di(n-butyl)tin oxide In toluene for 3h; Dehydration; Heating;95%
With triethylamine; 2,2,2-Trichloroethyl chloroformate In dichloromethane at 0 - 20℃; Elimination;92%
2-ethyl-4-pyridinaldehyde
10349-60-7

2-ethyl-4-pyridinaldehyde

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With Mont KSF; hydroxylamine hydrochloride; silica gel for 0.0666667h; microwave irradiation;94%
2-chloro-4-pyridinenitrile
33252-30-1

2-chloro-4-pyridinenitrile

triethylaluminum
97-93-8

triethylaluminum

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride In 1,4-dioxane; hexane at 100℃; for 5h; Inert atmosphere;89%
pyridine-4-carbonitrile
100-48-1

pyridine-4-carbonitrile

ethanol
64-17-5

ethanol

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With tert-butyl peroxypivalate; sulfuric acid at 75℃; for 4h; Product distribution; Mechanism;65%
With sulfuric acid; acetone Product distribution; Mechanism; Irradiation; mercury lamp;2%
With sulfuric acid Irradiation; Co-60 γ-rays;
2-ethyl-pyridine-4-carbaldehyde oxime

2-ethyl-pyridine-4-carbaldehyde oxime

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With aluminum oxide for 0.075h; microwave irradiation;60%
pyridine-4-carbonitrile
100-48-1

pyridine-4-carbonitrile

propionic acid
802294-64-0

propionic acid

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
With ammonium persulfate; sulfuric acid; silver nitrate In water at 70℃; for 0.333333h;48%
4-bromo-2-ethyl-pyridine
156761-88-5

4-bromo-2-ethyl-pyridine

CuCN

CuCN

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
at 160 - 170℃;
methyl 2-ethylpyridine-4-carboxylate
1531-16-4

methyl 2-ethylpyridine-4-carboxylate

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous NH3
2: POCl3 / 120 - 130 °C
View Scheme
ethyl 2-ethylisonicotinate
15862-61-0

ethyl 2-ethylisonicotinate

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous NH3
2: P2O5 / 160 - 180 °C
View Scheme
2-ethyl-6-chloro-isonicotinic acid methyl ester
4104-77-2

2-ethyl-6-chloro-isonicotinic acid methyl ester

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: palladium/charcoal; methanol; potassium acetate / Hydrogenation
2: aqueous NH3
3: POCl3 / 120 - 130 °C
View Scheme
2-ethyl-6-chloro-isonicotinic acid ethyl ester
4009-26-1

2-ethyl-6-chloro-isonicotinic acid ethyl ester

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: palladium/charcoal; ethanol; potassium acetate / Hydrogenation
2: aqueous NH3
3: P2O5 / 160 - 180 °C
View Scheme
4-amino-2-ethylpyridine
50826-64-7

4-amino-2-ethylpyridine

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: bromine; aqueous sodium nitrite solution; aqueous hydrobromic acid
2: 160 - 170 °C
View Scheme
2-ethylpyridine 1-oxide
4833-24-3

2-ethylpyridine 1-oxide

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sulfuric acid; nitric acid
2: iron; concentrated aqueous HCl; acetic acid
3: bromine; aqueous sodium nitrite solution; aqueous hydrobromic acid
4: 160 - 170 °C
View Scheme
2-ethyl-4-nitropyridine 1-oxide
38594-62-6

2-ethyl-4-nitropyridine 1-oxide

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: iron; concentrated aqueous HCl; acetic acid
2: bromine; aqueous sodium nitrite solution; aqueous hydrobromic acid
3: 160 - 170 °C
View Scheme
ethionamide
536-33-4

ethionamide

nicotinamide adenine dinucleotide
865-05-4

nicotinamide adenine dinucleotide

A

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

B

2-ethylpyridine-4-carboxylic acid
3376-96-3

2-ethylpyridine-4-carboxylic acid

C

2-ethyl-4-pyridinecarboxamide
3376-95-2

2-ethyl-4-pyridinecarboxamide

D

methyl 2-ethylpyridine-4-carboxylate
1531-16-4

methyl 2-ethylpyridine-4-carboxylate

E

C29H35N8O15P2(1+)

C29H35N8O15P2(1+)

F

ethionamide S-oxide

ethionamide S-oxide

Conditions
ConditionsYield
With Oxone In methanol; water at 20℃; for 1.5h;
ethionamide
536-33-4

ethionamide

A

2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

B

2-ethylpyridine-4-carboxylic acid
3376-96-3

2-ethylpyridine-4-carboxylic acid

C

2-ethyl-4-pyridinecarboxamide
3376-95-2

2-ethyl-4-pyridinecarboxamide

D

methyl 2-ethylpyridine-4-carboxylate
1531-16-4

methyl 2-ethylpyridine-4-carboxylate

E

ethionamide S-oxide

ethionamide S-oxide

F

C16H20N4

C16H20N4

Conditions
ConditionsYield
With Oxone In methanol; water at 20℃; for 0.0833333h;
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

2-ethyl-4-pyridinecarboxamide
3376-95-2

2-ethyl-4-pyridinecarboxamide

Conditions
ConditionsYield
With water at 110℃; for 24h;97%
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

1-(2-ethylpyridin-4-yl)methanamine
645418-40-2

1-(2-ethylpyridin-4-yl)methanamine

Conditions
ConditionsYield
With hydrogen; palladium(II) hydroxide; triethylamine In methanol at 20℃; under 3750.38 Torr; Autoclave;95%
With lithium aluminium tetrahydride In tetrahydrofuran at -78℃; for 0.5h;87%
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

ethionamide
536-33-4

ethionamide

Conditions
ConditionsYield
With 2,3,4,5,7,8,9,10-octahydropyrimido[1,2-a]azepin-1-ium acetate; sodiumsulfide nonahydrate In neat (no solvent) at 20℃; for 2h; Green chemistry;80%
Stage #1: 2-ethyl-4-pyridinecarbonitrile With magnesium chloride In N,N-dimethyl-formamide for 0.0833333h; Inert atmosphere;
Stage #2: With sodium hydrogen sulfide In N,N-dimethyl-formamide at 20℃; for 2h;
70%
With sodiumsulfide nonahydrate In N,N-dimethyl-formamide at 130℃; for 2.5h;67%
With triethanolamine; ethanol Einleiten von H2S;
With pyridine; triethylamine Einleiten von H2S;
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

1-triisopropylsiloxy-1-cyclohexene
80522-46-9

1-triisopropylsiloxy-1-cyclohexene

C22H37NOSi

C22H37NOSi

Conditions
ConditionsYield
With Ir(dF(CF3)ppy)2(bpy)PF6 In dichloromethane for 12h; Inert atmosphere; Sealed tube; Irradiation;71%
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

2-ethyl-4-pyridinaldehyde
10349-60-7

2-ethyl-4-pyridinaldehyde

Conditions
ConditionsYield
Stage #1: 2-ethyl-4-pyridinecarbonitrile With diisobutylaluminium hydride In hexane; toluene at -78 - 5℃;
Stage #2: With methanol In hexane; toluene at -78 - 5℃;
Stage #3: With water; rochelle salt In methanol; hexane; water; toluene for 0.05h;
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

bis(pinacol)diborane
73183-34-3

bis(pinacol)diborane

A

C14H19BN2O2
1438415-09-8

C14H19BN2O2

B

C20H30B2N2O4
1438415-08-7

C20H30B2N2O4

Conditions
ConditionsYield
With bis(1,5-cyclooctadiene)diiridium(I) dichloride In octane at 150℃; for 13h; Reflux; Inert atmosphere;A 16 %Spectr.
B 5 %Spectr.
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

2-(2-ethylpyridin-4-yl)-4-(2-methoxypyridin-4-yl)thiazole

2-(2-ethylpyridin-4-yl)-4-(2-methoxypyridin-4-yl)thiazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: magnesium chloride / N,N-dimethyl-formamide / 0.08 h / Inert atmosphere
1.2: 2 h / 20 °C
2.1: sodium hydroxide / 120 °C
View Scheme
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

4-(4-chlorophenyl)-2-(ethylpyridin-4-yl)thiazole
125255-97-2

4-(4-chlorophenyl)-2-(ethylpyridin-4-yl)thiazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: magnesium chloride / N,N-dimethyl-formamide / 0.08 h / Inert atmosphere
1.2: 2 h / 20 °C
2.1: ethanol / 80 °C
View Scheme
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

6-chloro-N-((2-ethylpyridin-4-yl)methyl)-3-(4-methoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine

6-chloro-N-((2-ethylpyridin-4-yl)methyl)-3-(4-methoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: palladium(II) hydroxide; triethylamine; hydrogen / methanol / 20 °C / 3750.38 Torr / Autoclave
2: N-ethyl-N,N-diisopropylamine / ethanol / 12 h / 75 °C
3: 1,4-dioxane; water / 16 h / Heating
View Scheme
2-ethyl-4-pyridinecarbonitrile
1531-18-6

2-ethyl-4-pyridinecarbonitrile

5-(6-chloro-8-(((2-ethylpyridin-4-yl)methyl)amino)-2-methylimidazo[1,2-b]pyridazin-3-yl)-2-methoxybenzenesulfonyl chloride

5-(6-chloro-8-(((2-ethylpyridin-4-yl)methyl)amino)-2-methylimidazo[1,2-b]pyridazin-3-yl)-2-methoxybenzenesulfonyl chloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: palladium(II) hydroxide; triethylamine; hydrogen / methanol / 20 °C / 3750.38 Torr / Autoclave
2: N-ethyl-N,N-diisopropylamine / ethanol / 12 h / 75 °C
3: 1,4-dioxane; water / 16 h / Heating
4: chlorosulfonic acid / dichloromethane / 4.5 h / 20 °C / Cooling with ice
View Scheme

1531-18-6Relevant articles and documents

Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology

Mejdrová, Ivana,Chalupská, Dominika,Pla?ková, Pavla,Müller, Christin,?ála, Michal,Klíma, Martin,Baumlová, Adriana,H?ebabecky, Hubert,Procházková, Eli?ka,Dejmek, Milan,Strunin, Dmytro,Weber, Jan,Lee, Gary,Matou?ová, Marika,Mertlíková-Kaiserová, Helena,Ziebuhr, John,Birkus, Gabriel,Boura, Evzen,Nencka, Radim

, p. 100 - 118 (2017)

Phosphatidylinositol 4-kinase IIIβ (PI4KB) is indispensable for the replication of various positive-sense single stranded RNA viruses, which hijack this cellular enzyme to remodel intracellular membranes of infected cells to set up the functional replication machinery. Therefore, the inhibition of this PI4K isoform leads to the arrest of viral replication. Here, we report on the synthesis of novel PI4KB inhibitors, which were rationally designed based on two distinct structural types of inhibitors that bind in the ATP binding side of PI4KB. These “hybrids” not only excel in outstanding inhibitory activity but also show high selectivity to PI4KB compared to other kinases. Thus, these compounds exert selective nanomolar or even subnanomolar activity against PI4KB as well as profound antiviral effect against hepatitis C virus, human rhinovirus, and coxsackievirus B3. Our crystallographic analysis unveiled the exact position of the side chains and explains their extensive contribution to the inhibitory activity.

SUBSTITUTION OF ALKYL AND HYDROXYALKYL GROUP FOR RING HYDROGEN AND OF HYDROXYALKYL GROUP FOR CYANO GROUP IN GAMMA-IRRADIATION OF PYRIDINECARBONITRILES IN ALCOHOL

Sugimori, Akira,Mori, Shoji,Maeda, Kazuo,Nishijima, Masayuki

, p. 769 - 772 (1984)

Gamma-irradiation of pyridinecarbonitriles in alcohol in the presence of sulfuric acid brings about the substitution of the alkyl group derived from alcohol for,the ring hydrogen, while that in the absence of sulfuric acid causes the substitution of hydroxyalkyl group for CN at the 2- and 4-positions.Hydroxyalkyl radicals and solvated electrons play important role in the substitution.

Preparation method of 2-ethyl-4-cyanopyridine

-

Paragraph 0017; 0024; 0026; 0028; 0031-0032, (2021/01/20)

The invention provides a preparation method of 2-ethyl-4-cyanopyridine. According to the preparation method, 1-(4-bromopyridin-2-yl)ethanone is used as an initial raw material, 2-ethyl-4-bromopyridineis prepared through reduction of a catalyst and a reducing agent, and 2-ethyl-4-cyanopyridine is obtained through cyanation. The total yield is 85% or more, and the product purity is 99% or more. Theroute is simple and convenient, auxiliary materials are common compounds, and the solvent can be recycled. The product is a single compound. Compared with a traditional synthesis method, the synthesis method has the advantages that isomer 3-ethyl-4-cyanopyridine is not generated, and the requirement for post-treatment of synthesis of ethylthio isonicotinamide is low. The synthetic route is safe,simple and convenient to operate, environment-friendly, capable of relaxing the bowels and suitable for industrial production.

Diarylthiazole: An antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system

Bellale, Eknath,Naik, Maruti,Vb, Varun,Ambady, Anisha,Narayan, Ashwini,Ravishankar, Sudha,Ramachandran, Vasanthi,Kaur, Parvinder,McLaughlin, Robert,Whiteaker, James,Morayya, Sapna,Guptha, Supreeth,Sharma, Sreevalli,Raichurkar, Anandkumar,Awasthy, Disha,Achar, Vijayshree,Vachaspati, Prakash,Bandodkar, Balachandra,Panda, Manoranjan,Chatterji, Monalisa

supporting information, p. 6572 - 6582 (2014/10/15)

Diarylthiazole (DAT), a hit from diversity screening, was found to have potent antimycobacterial activity against Mycobacterium tuberculosis (Mtb). In a systematic medicinal chemistry exploration, we demonstrated chemical opportunities to optimize the potency and physicochemical properties. The effort led to more than 10 compounds with submicromolar MICs and desirable physicochemical properties. The potent antimycobacterial activity, in conjunction with low molecular weight, made the series an attractive lead (antibacterial ligand efficiency (ALE) >0.4). The series exhibited excellent bactericidal activity and was active against drug-sensitive and resistant Mtb. Mutational analysis showed that mutations in prrB impart resistance to DAT compounds but not to reference drugs tested. The sensor kinase PrrB belongs to the PrrBA two component system and is potentially the target for DAT. PrrBA is a conserved, essential regulatory mechanism in Mtb and has been shown to have a role in virulence and metabolic adaptation to stress. Hence, DATs provide an opportunity to understand a completely new target system for antimycobacterial drug discovery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1531-18-6